Welcome to our dedicated page for Chemed news (Ticker: CHE), a resource for investors and traders seeking the latest updates and insights on Chemed stock.
Chemed Corporation (NYSE: CHE) is a Cincinnati-based holding company that operates two distinct businesses: VITAS Healthcare and Roto-Rooter. This news page aggregates press releases and third-party coverage related to Chemed’s hospice operations and plumbing and drain cleaning services, giving investors and observers a single place to review company developments.
VITAS Healthcare is described by the company as the nation’s largest provider of end-of-life hospice care. News about VITAS often covers quarterly financial results, trends in net patient revenue, average daily census, admissions, Medicare reimbursement dynamics, and Medicare Cap billing limitations, particularly in key markets such as Florida and California. Updates can also include regulatory milestones, such as Certificates of Need in new counties, and changes in leadership at the VITAS level.
Roto-Rooter is characterized as the nation’s leading provider of plumbing and drain cleaning services. Coverage related to this segment typically includes segment revenue performance, commercial and residential demand trends, and results in service categories such as plumbing, drain cleaning, excavation, and water restoration. Company communications also discuss how Roto-Rooter operates through branches, independent contractors, franchisees, and licensed master franchisees in several countries.
Chemed regularly issues announcements about quarterly earnings, guidance revisions, dividend declarations, stock repurchase authorizations, and participation in healthcare and home care conferences. This news feed allows readers to follow how VITAS and Roto-Rooter contribute to consolidated results, how management responds to reimbursement and demand conditions, and how capital allocation decisions such as dividends and buybacks evolve over time.
For anyone tracking CHE, this page provides a convenient way to review historical and recent news items related to the company’s hospice care and plumbing and drain cleaning operations.
VITAS Healthcare (NYSE:CHE) opened its first inpatient hospice center in Pinellas County at Oak Manor in Largo on March 11, 2026, expanding local end-of-life services.
The 12-room facility provides 24/7 clinical care, high-acuity support and is expected to care for 400+ patients annually, plus family respite and community outreach.
Chemed (NYSE:CHE) will present virtually at the Oppenheimer 36th Annual Healthcare Conference on March 19, 2026 at ~9:20 a.m. ET. The live webcast and presentation materials will be available on Chemed's investor site, with a replay posted within 24 hours and accessible for 90 days.
Chemed operates two subsidiaries: VITAS Healthcare (hospice) and Roto-Rooter (plumbing and drain services), and cautioned that forward-looking statements are subject to risks and may change.
Chemed (NYSE: CHE) reported Q4 2025 results: consolidated revenue of $639.3M (flat YoY), GAAP diluted EPS of $5.48 (down 9.0%) and adjusted diluted EPS of $6.42 (down 6.0%).
VITAS net patient revenue was $418.8M (+1.9%), ADC 22,462 (+1.3%), admissions +6.0%. Roto-Rooter revenue was $220.6M (-3.7%) with adjusted EBITDA down 21.1%.
Chemed ended 12/31/2025 with $74.5M cash, no debt, repurchased 400,000 shares for $174.6M, and issued 2026 guidance of adjusted EPS $23.25–$24.25.
Chemed (NYSE:CHE) authorized an additional $300 million for share repurchases under its existing program and will fund buybacks with cash from operations and its revolving credit facility. The Board also declared a $0.60 quarterly dividend payable March 13, 2026, to holders of record Feb 23, 2026.
This marks Chemed's 219th consecutive quarterly dividend over 54 years as a public company. Operations include VITAS Healthcare and Roto-Rooter.
Chemed (NYSE: CHE) will release fourth-quarter 2025 financial results for the period ended December 31, 2025 on Wednesday, February 25, 2026 after market close. The company will host a conference call and webcast at 10:00 a.m. ET on Thursday, February 26, 2026 to discuss results and provide a business update.
Investors may access a live webcast via Chemed's Investor Relations website or the provided media-server link. Registration for teleconference dial-in is required and will provide a personalized conference code; callers are asked to dial in 15 minutes early. A taped replay will be available roughly two hours after the call via the investor relations webcast. Chemed operates two subsidiaries: VITAS Healthcare and Roto-Rooter.
Chemed Corporation (NYSE:CHE) will present at the BofA Securities 2025 Virtual Home Care Conference on Tuesday, December 9, 2025 at 1:20 PM ET. The presentation will be webcast live and presentation materials will be available on Chemed's investor relations website at www.chemed.com.
The webcast replay will be posted within 24 hours of the live presentation and will remain accessible for 90 days. Chemed operates two subsidiaries: VITAS Healthcare (end-of-life hospice services) and Roto-Rooter (plumbing and drain cleaning services). The company cautions that any forward-looking statements are subject to risks and may differ materially.
VITAS Healthcare (NYSE:CHE) on November 25, 2025 released a video during National Care at Home Month that profiles caregiver Stacy Noland and her mother, Sonia Lindo, highlighting hospice care at home.
The video describes how VITAS teams enabled comfort and dignity during Lindo’s terminal illness, eased caregiver strain, and provided holistic support from nurses, aides, social workers, chaplains and bereavement specialists. Viewers are directed to watch Stacy’s story and to learn more at VITAS.com or call 800.93.VITAS.
Chemed (NYSE:CHE) declared a quarterly cash dividend of $0.60 per share, payable on December 5, 2025 to shareholders of record as of November 17, 2025. The dividend equals the amount paid in August 2025 and marks Chemed's 218th consecutive quarterly dividend during 54 years as a public company.
Chemed operates two subsidiaries: VITAS Healthcare (hospice services) and Roto-Rooter (plumbing and drain services). The release includes standard forward-looking statement cautions and a contact for investor inquiries.
Chemed Corporation (NYSE: CHE) will present at the UBS 2025 Global Healthcare Conference on Tuesday, November 11, 2025 at ~2:00 p.m. ET at PGA National Resort in Palm Beach Gardens, Florida.
The presentation will be webcast live and presentation materials will be posted on Chemed's Investor Relations website at www.chemed.com. A replay will be available within 24 hours and accessible for 90 days. Chemed operates two subsidiaries, VITAS Healthcare and Roto-Rooter. Forward-looking statements in the release are subject to risks and may change; Chemed does not assume an obligation to update them.
Chemed (NYSE:CHE) reported Q3 2025 revenue of $624.9M, up 3.1% year-over-year, with GAAP diluted EPS $4.46 (down 10.8%) and Adjusted diluted EPS $5.27 (down 6.6%).
VITAS net patient revenue was $407.7M (+4.2%), average daily census 22,327 (+2.5%), admissions 17,714 (+5.6%), and adjusted EBITDA excluding Medicare Cap $70.4M (margin 17.0%, -157 bps). Roto-Rooter revenue was $217.2M (+1.1%) with adjusted EBITDA $49.4M (margin 22.7%, -351 bps).
Cash and equivalents were $129.8M with no debt; the company repurchased 407,500 shares for $180.8M and reiterated 2025 adjusted EPS guidance of $22.00–$22.30.